Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) — Cash Flow Reinvestment Rate
Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has a Cash Flow Reinvestment Rate of 0.13x as of March 2026, reinvesting TL24.08 Million (capex TL24.08 Million ) from operating cash flow of TL180.45 Million. Check cash flow quality index of Meditera Tibbi Malzeme Sanayi ve Ticaret to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Meditera Tibbi Malzeme Sanayi ve Ticaret AS across 8 annual periods. Explore Meditera Tibbi Malzeme Sanayi ve Ticaret debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2025)
Year-by-year capital reinvestment analysis for Meditera Tibbi Malzeme Sanayi ve Ticaret AS. For live market cap and broader valuation context, see market cap of Meditera Tibbi Malzeme Sanayi ve Ticaret.
| Year | Reinvestment Rate | Total Reinvested (TRY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | TL191.67 Million | TL435.35 Million | TL191.67 Million | ▼ -18.8% |
| 2024 | 0.54x | TL423.12 Million | TL780.69 Million | TL263.52 Million | ▲ +4.1% |
| 2023 | 0.52x | TL417.10 Million | TL801.02 Million | TL299.70 Million | ▼ -97.2% |
| 2022 | 18.59x | TL94.79 Million | TL5.10 Million | TL51.35 Million | ▲ +4366.2% |
| 2021 | 0.42x | TL15.25 Million | TL36.64 Million | TL8.92 Million | ▲ +46.0% |
| 2020 | 0.29x | TL20.89 Million | TL73.26 Million | TL20.85 Million | ▼ -54.1% |
| 2019 | 0.62x | TL12.42 Million | TL20.01 Million | TL0.00 | ▲ +101.7% |
| 2018 | 0.31x | TL22.55 Million | TL73.26 Million | TL0.00 | — |